The exploratory outcomes are other inflammatory markers and the patient-reported outcomes ASDAS-CRP, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), quality of life measures (SF-36, EQ-5D, EQ-5D VAS), and hospital anxiety and depression (HADS). The gene discussed is CRP; the disease is Anxiety.